Jay Moorin
Direktor/Vorstandsmitglied bei Equinox Funds Trust
Ursprung des Netzwerks ersten Grades von Jay Moorin
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 18 | |
ProQuest Management LLC
ProQuest Management LLC Investment ManagersFinance ProQuest Management LLC (ProQuest Management) is a venture capital firm founded in 1998 by Jay Moorin. The firm headquartered in Naples, Florida.
17
| Extinct | Investment Managers | 17 |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA.
14
| Extinct | Pharmaceuticals: Major | 14 |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO.
12
| Extinct | Pharmaceuticals: Major | 12 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA.
8
| Extinct | Pharmaceuticals: Major | 8 |
Subsidiary | Biotechnology | 8 | |
Extinct | Oil & Gas Production | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jay Moorin
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Founder Founder Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ZP Opco, Inc.
ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Graduate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Corporate Officer/Principal | |
AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Director/Board Member Consultant / Advisor | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of Michigan | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Consultant / Advisor | |
Prostate Cancer Foundation | Investment Trusts/Mutual Funds | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Investment Committee Member Investment Committee Member | |
GeneOhm Sciences, Inc.
GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chairman | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | President Chairman | |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Illinois | College/University | Doctorate Degree Undergraduate Degree | |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Missouri | College/University | Doctorate Degree Masters Business Admin | |
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Investment Managers | Consultant / Advisor Private Equity Investor | |
The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Santa Clara University | College/University | Undergraduate Degree Masters Business Admin | |
Haas School of Business | College/University | Masters Business Admin Masters Business Admin | |
Stanford University | College/University | Undergraduate Degree Masters Business Admin | |
Collabra Pharma, Inc. | Founder Corporate Officer/Principal | ||
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree Undergraduate Degree | |
AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
University of California, Los Angeles | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer Director/Board Member |
Statistik
International
Vereinigte Staaten | 51 |
Sektoral
Health Technology | 27 |
Consumer Services | 15 |
Finance | 5 |
Health Services | 4 |
Miscellaneous | 2 |
Operativ
Director/Board Member | 442 |
Corporate Officer/Principal | 223 |
Independent Dir/Board Member | 107 |
Chairman | 98 |
Chief Executive Officer | 63 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
James Healy | 50 |
Michael Barrett | 49 |
James Blair | 48 |
Daniel Bradbury | 45 |
Peter Thompson | 39 |
John P. Walker | 39 |
Camille Samuels | 30 |
Samuel Saks | 28 |
Judith Ann Hemberger | 26 |
Alain B. Schreiber | 25 |
David Drutz | 24 |
Wendy Johnson | 23 |
Lowell E. Sears | 22 |
Sander A. Flaum | 21 |
John Reed | 20 |
- Börse
- Insiders
- Jay Moorin
- Unternehmensverbindungen